The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Thoth2 - as a first step the requirement to remove Parker and cancel his options based on his apparent non-performance should send a very clear message to TM and JR. If TM can provide robust evidence that Parker has added significant value then further consideration may be required.
Add my 1 million to your totals as well.
I have just t under a mill to add if required
Agree 100 percent...need answers before we get diluted to extinction .......fed up how even about chk1 phase 2 money activation clause was hidden from shareholders .....not very decent. ..
Thoth, I only have a couple of million shares but happy to add to the collective. I think we have all been very patient.
ATB
Seawolf
Give us collectively a week.we are sounding out caretakers /chairmen/dealmakers amongst our networks worst case wont be a poorer return than to date
HI thoth. Yeah it's time to strike now while we can ...the silence is deafening. ....either they tell us what is going on in our company or we put our foot down....I would happily sell at moment for 5p ...God never thought that before ....all we get from sareum is rns all stating more dilution. ..diluting. ...surprised not making orange juice . I say we all need to strike now. ..please tell us what you would like next. All your help appreciated
We will be discussing offline but my thrust subject to support from the major shareholders.
1. Oust parker for failure to get any institutions on board.
2. Block reappointment of any directors and advisers. Because we can
If no notice is taken of that flexing
3. Cancelling of existing options. (Bit more complicated but actually not really complicated)
4. Fire all staff saving 600k a year. Put in a caretaker (crt will manage the chk1 contract and pay us ) tyk2 put an agent on commission.
This approach will avoid us being diluted over the next 5 years on aspirations without evidence of work being done.
I am more interested in maintaining my pension. Than feathering Tim's for another 5 years at the expense of mine and my family's.
Emails are out to opt out or opt in. Pls respond over weekend. All opted in so far end enough votes to Muller any motion. It is our company and the executive operate at our direction. Just need to organise which we have. A parliament Brexit government analogy but we own the company and will not be taken for fools
https://quoteddata.com/2019/07/trust-favourite-gilead-expands-deal-galapagos/
note the last sentence.. why not partnered. molecule no good. business development useless. or we dont need the cash and would rather have another dilution. Ill do the emails this weekend as I have less on then.
RMM-very droll!!
Unfortunately bit too close to reality for comfort.
Tim & Co are doing a Blackadder in the trenches well behind the parapet hoping the probable forthcoming assault by shareholders will not happen. How long before Parker turns and runs I wonder.
I was dreaming of 28p. Unfortunately the nightmare of .38p is a lot closer.
Still waiting.
KR
ZA
Just out of interest has anyone purchased and read the full publication of T.Sen at MD Anderson SCLC, I purchased and have had a good read, wondering how many people here has read it, cost was £29 roughly!
It not a bad dream- It's a bloody nightmare on elm street with kruger posing as parker. No one ever said pharma was short-term investment- for me the silence has all the hallmarks of the silence leading up to the Chk1 licencing deal albeit with Tyk2 100% owned and a potentially bigger market as the recent Celgene deal has indicated and by what Sar projected in the final RNS (i.e. the deal sizes). I take great encouragement from the fact the Pfizer's Tofa is on the market turning over $1.8bn per annum and they know that our Tyk2 is better in the RA studies they conducted and funded- so it's just a matter of time before the inevitable deal lands.
Unfortunately I can see the next update already..... 'We have delivered significant value to shareholders with the SP having doubled from 0.2p to 0.4p. This is a transformational change and shows real progress in our drive to deliver a best in class, last in the market product. We continue to hold conversations with global pharmaceutical companies but none of them are talking back to us. In the meantime I am pleased to announce another placing of 500m shares which after costs and salaries has placed a net 2 shillings and sixpence in the companies bank account'. Please tell me it was just a bad dream....
Arghhhh ... how low can we go ... roll on the 0.4p party
Sometimes I think I am on a different board to the share!
Maybe I was optimistic and should have said “roll on the 0.5p party first” ... given the attitude of the MMs dropping this by 6% on little volume in the last few days ....
Krone, I wouldn't hold these words to account, his favourite word before that was transformational...
Yet we look to be the inverse of that.
I'll hold and add when available until TYK2 data published.
GLA
Being pedantic Tim does say ‘over’ the next 12 months which may suggest a series of value increases as opposed to a single event?
I won't hold him to the timescale exactly because I believe we'll put TYK2 in P1 before anything big happens. I guess by next June, we will know when the trails are staring? And hopefully be flush with milestones.
Tim has actually indicated 'significant value' three times since March 2019
26/6/2019 - We believe we have the potential to generate significant value with these candidates, which represent exciting prospects in an area of increasing interest in the pharmaceutical industry.
13/6/2019 - We believe there is a clear opportunity to generate significant value for our shareholders over the next 12 months, given recent progress with both our clinical and preclinical programmes.
4/3/2019 - advancing these two programmes as quickly and as rigorously as possible is the focus of all our current resources and we are convinced that they offer the potential to generate significant value for shareholders.”
Tim has stuck his head above the parapet and said significant value within 12 months. Only 9 months to go. He's been burnt before with this sort of thing. Hopefully, he believes the statement to be true this time.
Potnak, I agree. It very much seems like an endgame scenario, especially as they do not seem to be showing any interest in producing anything further from the SKIL Platform.
What I mean about their age is this isn't a long term plan.